z-logo
open-access-imgOpen Access
What are the Factors that Could Contribute to the Lower Risk of Major Bleeding with Bivalirudin Compared with Unfractionated Heparin for Percutaneous Coronary Intervention?
Author(s) -
Ahmed N. Mahmoud,
Anthony A. Bavry,
Islam Y. Elgendy
Publication year - 2017
Publication title -
international cardiovascular forum journal
Language(s) - English
Resource type - Journals
eISSN - 2410-2636
pISSN - 2409-3424
DOI - 10.17987/icfj.v9i0.359
Subject(s) - bivalirudin , percutaneous coronary intervention , heparin , medicine , cardiology , myocardial infarction

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom